WEBSTER ARTHUR PTY LTD has a total of 12 patent applications. Its first patent ever was published in 1990. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and New Zealand. Its main competitors in its focus markets biotechnology, pharmaceuticals and machines are ZHAOQING DAHUANONG BIOLOGIC PHARMACEUTICAL CO LTD, FLUGEN INC and DCPRIME B V.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | New Zealand | 2 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Therapeutic chemical compounds | |
#5 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Mcgavin David Ross | 6 |
#2 | Lavidis Lynette | 4 |
#3 | Sheppard Michael | 3 |
#4 | Mccoy Richard | 3 |
#5 | Erny Katrina | 3 |
#6 | Werner Wendy | 3 |
#7 | Bagust Trevor John | 2 |
#8 | Kongsuwan Kritaya | 2 |
#9 | Johnson Michael | 2 |
#10 | Fahey Kevin John | 2 |
Publication | Filing date | Title |
---|---|---|
AU6499494A | Recombinant avian adenovirus vector | |
NZ263772A | Recombinant avian adenovirus with heterologous nucleotide sequence; use as vector; vaccine | |
AU8406191A | Infectious laryngotracheitis virus vaccine | |
WO9203554A1 | Infectious laryngotracheitis virus vaccine | |
EP0485463A1 | Attenuated canine parvovirus (cpv), vaccine comprising cpv and method of preventing infection by cpv in dogs | |
AU6152390A | Attenuated canine parvovirus (cpv), vaccine comprising cpv and method of preventing infection by cpv in dogs | |
US5436005A | Low virulence infectiouns laryngotracheitis (ILT) virus for vaccinating birds | |
AU6061890A | Low virulence laryngotracheitis (ILT) virus for vaccinating birds |